ResearcherPeking UniversityActive in the last 2 years
Sihan Huo
Matched on ORCID iD 0009-0000-7327-6102; OpenAlex author ID A5005938269. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2024: 1 paper · 2025: none · 2026: 2 papers
Papers 3
- CAFs shape the immunosuppressive microenvironment of pancreatic cancer through the Lin28b-STING Axis. Co-author DOI 10.1038/s41467-026-76495-3↗
- KRAS Inhibitor Resistance Confers a Targetable Vulnerability to Ferroptosis in Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-26-1490↗
- UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis. First author DOI 10.1016/j.celrep.2024.113808↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ying Zhao · 3 shared papers, 2024–2026 · strength 0.74
- Paper CAFs shape the immunosuppressive microenvironment of pancreatic cancer through the Lin28b-STING Axis. DOI 10.1038/s41467-026-76495-3↗
- Paper KRAS Inhibitor Resistance Confers a Targetable Vulnerability to Ferroptosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/0008-5472.can-26-1490↗
- Paper UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis. DOI 10.1016/j.celrep.2024.113808↗
- Minghe Fan · 3 shared papers, 2024–2026 · strength 0.74
- Paper CAFs shape the immunosuppressive microenvironment of pancreatic cancer through the Lin28b-STING Axis. DOI 10.1038/s41467-026-76495-3↗
- Paper KRAS Inhibitor Resistance Confers a Targetable Vulnerability to Ferroptosis in Pancreatic Ductal Adenocarcinoma. DOI 10.1158/0008-5472.can-26-1490↗
- Paper UDP-glucose dehydrogenase supports autophagy-deficient PDAC growth via increasing hyaluronic acid biosynthesis. DOI 10.1016/j.celrep.2024.113808↗
- Jingfeng Tang · 1 shared paper, 2026 · strength 0.26
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.